Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 540737 | NSE: Not Listed

785.60
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  800.00
  •  823.00
  •  761.15
  •  837.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  26647
  •  209.83
  •  950.05
  •  557.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 948.44
  • 32.64
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 967.41
  • N/A
  • 6.85

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.80%
  • 1.24%
  • 24.88%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 1.07%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.53
  • 16.59
  • 20.87

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.37
  • 30.74
  • 18.47

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 36.31
  • 23.93
  • 28.03

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.14
  • 30.35
  • 30.72

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.95
  • 5.97
  • 6.28

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.85
  • 18.14
  • 19.04

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
27.05
0.00
0
32.33
0.00
0
24.78
0.00
0
37.33
0.00
0
Expenses
17.15
0.00
0
21.02
0.00
0
16.66
0.00
0
20.40
0.00
0
EBITDA
9.90
0.00
0
11.31
0.00
0
8.12
0.00
0
16.93
0.00
0
EBIDTM
36.59%
0.00%
34.98%
0.00%
32.78%
0.00%
45.35%
0.00%
Other Income
0.71
0.00
0
0.19
0.00
0
0.55
0.00
0
1.32
0.00
0
Interest
0.39
0.00
0
0.44
0.00
0
0.32
0.00
0
0.16
0.00
0
Depreciation
2.70
0.00
0
2.42
0.00
0
2.02
0.00
0
1.86
0.00
0
PBT
7.53
0.00
0
8.64
0.00
0
6.33
0.00
0
16.24
0.00
0
Tax
2.10
0.00
0
2.23
0.00
0
1.68
0.00
0
3.66
0.00
0
PAT
5.42
0.00
0
6.41
0.00
0
4.65
0.00
0
12.58
0.00
0
PATM
20.05%
0.00%
19.81%
0.00%
18.76%
0.00%
33.71%
0.00%
EPS
4.22
0.00
0
4.99
0.00
0
3.62
0.00
0
10.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 20
Mar 19
Net Sales
-
125.90
64.02
35.31
Net Sales Growth
-
96.66%
81.31%
 
Cost Of Goods Sold
-
57.45
37.92
18.50
Gross Profit
-
68.45
26.10
16.82
GP Margin
-
54.37%
40.77%
47.64%
Total Expenditure
-
84.09
51.50
26.57
Power & Fuel Cost
-
6.39
1.54
0.85
% Of Sales
-
5.08%
2.41%
2.41%
Employee Cost
-
8.41
2.90
1.63
% Of Sales
-
6.68%
4.53%
4.62%
Manufacturing Exp.
-
4.82
0.70
0.56
% Of Sales
-
3.83%
1.09%
1.59%
General & Admin Exp.
-
2.48
6.93
3.69
% Of Sales
-
1.97%
10.82%
10.45%
Selling & Distn. Exp.
-
3.95
1.23
1.18
% Of Sales
-
3.14%
1.92%
3.34%
Miscellaneous Exp.
-
0.60
0.28
0.17
% Of Sales
-
0.48%
0.44%
0.48%
EBITDA
-
41.81
12.52
8.74
EBITDA Margin
-
33.21%
19.56%
24.75%
Other Income
-
3.07
3.91
1.17
Interest
-
0.61
0.54
0.20
Depreciation
-
6.11
2.29
1.04
PBT
-
38.16
13.59
8.67
Tax
-
10.05
3.12
2.43
Tax Rate
-
26.34%
22.96%
28.03%
PAT
-
28.11
10.47
6.24
PAT before Minority Interest
-
28.11
10.47
6.24
Minority Interest
-
0.00
0.00
0.00
PAT Margin
-
22.33%
16.35%
17.67%
PAT Growth
-
168.48%
67.79%
 
EPS
-
21.96
8.18
4.88

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 20
Mar 19
Shareholder's Funds
122.10
42.20
33.82
Share Capital
12.84
8.97
8.97
Total Reserves
109.25
33.23
24.85
Non-Current Liabilities
30.16
2.65
0.73
Secured Loans
29.12
0.04
0.24
Unsecured Loans
0.00
2.15
0.00
Long Term Provisions
0.33
0.18
0.16
Current Liabilities
25.96
10.38
6.79
Trade Payables
8.19
4.52
3.90
Other Current Liabilities
8.30
0.20
0.18
Short Term Borrowings
0.71
2.07
0.33
Short Term Provisions
8.76
3.59
2.39
Total Liabilities
178.22
55.27
41.34
Net Block
80.55
20.14
14.50
Gross Block
105.23
28.81
21.05
Accumulated Depreciation
24.68
8.68
6.55
Non Current Assets
100.73
21.46
15.53
Capital Work in Progress
16.92
0.00
0.00
Non Current Investment
0.08
0.07
0.05
Long Term Loans & Adv.
3.18
1.06
0.72
Other Non Current Assets
0.01
0.20
0.27
Current Assets
77.48
33.82
25.81
Current Investments
4.66
3.00
4.00
Inventories
24.99
6.41
6.51
Sundry Debtors
20.33
17.79
9.72
Cash & Bank
16.26
2.33
1.00
Other Current Assets
11.23
0.00
0.00
Short Term Loans & Adv.
10.43
4.29
4.58
Net Current Assets
51.52
23.44
19.02
Total Assets
178.21
55.28
41.34

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 20
Mar 19
Cash From Operating Activity
30.45
4.59
-5.22
PBT
38.16
13.59
8.67
Adjustment
5.89
-3.66
-0.35
Changes in Working Capital
-5.47
-5.34
-13.53
Cash after chg. in Working capital
38.59
4.59
-5.22
Interest Paid
0.00
0.00
0.00
Tax Paid
-8.14
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-33.01
-2.91
-0.08
Net Fixed Assets
-97.03
-4.07
Net Investments
2.28
-3.05
Others
61.74
4.21
Cash from Financing Activity
9.84
-0.48
-0.18
Net Cash Inflow / Outflow
7.28
1.20
-5.47
Opening Cash & Equivalents
8.66
1.13
6.46
Closing Cash & Equivalent
15.85
2.33
0.99

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 20
Mar 19
Book Value (Rs.)
95.07
35.14
33.80
ROA
24.08%
21.67%
15.08%
ROE
34.22%
27.55%
18.43%
ROCE
37.81%
34.79%
25.66%
Fixed Asset Turnover
1.93
2.57
1.68
Receivable days
53.79
78.42
100.48
Inventory Days
44.31
36.84
67.29
Payable days
40.38
32.14
54.62
Cash Conversion Cycle
57.72
83.12
113.16
Total Debt/Equity
0.30
0.11
0.02
Interest Cover
63.85
26.05
43.45

News Update:


  • Shree Ganesh Remed. - Quarterly Results
    5th Feb 2025, 14:58 PM

    Read More
  • Shree Ganesh Remedies executes supply agreement with Japanese firm
    31st Jan 2025, 10:16 AM

    The agreement, formalised on January 30, 2025, is set for an initial term of three years, with the potential for extension by an additional two years

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.